fashion -WSS

fashion

author：leisure time 2025-09-30 23:10:59 - browse：9

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： KalVista pill reduced swelling 'attacks' caused by genetic disease

explore

WSS

Children’s Hospital revives plan for pedestrian bridge

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Biogen Alzheimer’s drug launch off to slow start

Virtual repurposing can help discover new uses for existing drugs

Ohio train derailment: Experts on toxic chemical risks

Medicare Advantage isn’t working — for anyone

focus

fashion

hotspot

Peter Hotez and the public health issue of online harassment

Key House Republican on health care plans exit from Congress

The cancer drug shortage isn’t new — and neither are the solutions

KalVista pill reduced swelling 'attacks' caused by genetic disease

Hepatitis C has a cure — but many Americans still lack access to it

Using force crossed my mind when examining a defiant young patient

In age of alternative facts, a scholarly course on calling out crap

PhRMA lawsuit over Medicare drug price negotiation tossed

In Memoriam: Notable people who died in 2023

'Vaccine

focus

Change Healthcare cyberattack shows risk of industry consolidation

BioAge raises $170M for combination therapy with Zepbound

Robert F. Kennedy is pitching centrism on health, even on abortion

Using force crossed my mind when examining a defiant young patient

Color Health wants to make cancer screenings convenient

Readout LOUD podcast: How biotech is using artificial intelligence

hotspot

explore

explore

knowledge